Dosage and administration
Adults & Children ages 7 - 12: 4 tablets. Children ages 2 - 6: 2 tablets. Dissolve under tongue 3 times a day. Use more frequently (every 15 minutes for up to 8 doses) with acute conditions.
#5 Kali Mur. 6X 500 Tablets
- Manufacturer
- Hyland's Inc.
- Effective date
- 2022-12-19
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 4
- Source
- full-release
- Hydrated at
- 2026-06-01 02:18:57
Label at a glance#
ProductKALI MURIATICUM
Active ingredientPOTASSIUM CHLORIDE
Label structure6 sections
Contacts and useful links#
Label contents#
Full prescribing information#
DIRECTIONS
Adults & Children ages 7 - 12: 4 tablets. Children ages 2 - 6: 2 tablets. Dissolve under tongue 3 times a day. Use more frequently (every 15 minutes for up to 8 doses) with acute conditions.
INDICATIONS
OTC - PURPOSE SECTION
Relief of symptoms of colds, sore throat and runny nose with a white discharge.
FORMULA
Kali Muriaticum 6X HPUS
INACTIVE INGREDIENT SECTION
In a base of Acacia Gum, Lactose N.F.
“HPUS” indicates that the active ingredients are in the official Homeopathic Pharmacopœia of the United States.
Warnings
OTC - DO NOT USE SECTION
Do not use if imprinted cap band is broken or missing.
OTC - ASK DOCTOR/PHARMACIST SECTION
If symptoms persist for more than seven days or worsen, contact a licensed health care provider.
OTC - STOP USE SECTION
Discontinue use if symptoms are accompanied by a high fever (over 101° F). Severe or persistent sore throat accompanied by high fever, headache, nausea, and vomiting may be serious. Consult physician promptly.
OTC - DO NOT USE SECTION
Do not use more than 2 days or administer to children under three years of age unless directed by physician.
OTC - PREGNANCY OR BREAST FEEDING SECTION
If you are pregnant or nursing, seek the advice of a licensed health care provider before using this product.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep this and all medications out of the reach of children.
QUESTIONS?
(800) 624-9659
PRINCIPAL DISPLAY PANEL - 500 Tablet Bottle Label
HOMEOPATHIC
NDC 54973-5224-1
Hyland's
#5
Kali Mur. 6X
Colds, Sore Throat,
Runny Nose*
500 TABLETS
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 54973-5224-1 | KALI MURIATICUM | 500 in 1 BOTTLE, PLASTIC | TABLET | 500 | 4 | |
| 54973-5224-2 | KALI MURIATICUM | 1000 in 1 BOTTLE, PLASTIC | TABLET | 1000 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 54973-5224 | KALI MURIATICUM (POTASSIUM CHLORIDE) TABLET [HYLAND'S INC.] | 4 | Current NDC, Legacy NDC, 2 package rows | 20221220_2e8a4762-d28d-4b64-892f-913e04d18d2d.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| POTASSIUM CHLORIDE | ACTIVE INGREDIENT | 660YQ98I10 | 1 | |
| POTASSIUM CATION | ACTIVE MOIETY | 295O53K152 | 1 | |
| ACACIA | INACTIVE INGREDIENT | 5C5403N26O | 1 | |
| LACTOSE | INACTIVE INGREDIENT | J2B2A4N98G | 1 |
Products#
Every source-derived product name is available through these pages.
- KALI MURIATICUM
- potassium chloride
- ACACIA
- LACTOSE
- POTASSIUM CATION
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 54973-5224 | 54973-5224-1, 54973-5224-2 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ACACIA | 5C5403N26O | IACT |
| LACTOSE | J2B2A4N98G | IACT |
| POTASSIUM CHLORIDE | 660YQ98I10 | ACTIB |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET / ORAL | 2500 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET / ORAL | 2500 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET / ORAL | 2500 mg | ||
| ACACIA | ACACIA | 5C5403N26O | TABLET / ORAL | 70 mg | ||
| ACACIA | ACACIA | 5C5403N26O | TABLET / ORAL | 70 mg | ||
| ACACIA | ACACIA | 5C5403N26O | TABLET / ORAL | 70 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| KALI MURIATICUM | POTASSIUM CHLORIDE | Hyland's Inc. | 2e8a4762-d28d-4b64-892f-913e04d18d2d | 2022-12-19 | Warnings | 54973-5224-1 54973-5224-2 54973-5224 54973522401 54973522402 f032ca21-e3ef-78b6-e053-2a95a90af8c4 2e8a4762-d28d-4b64-892f-913e04d18d2d |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.